# Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis

> **NCT00273247** · PHASE3 · COMPLETED · sponsor: **National Cancer Institute, Milan** · enrollment: 150 (—)

## Conditions studied

- Hepatocellular Carcinoma
- Hepatitis C Virus Infection
- Liver Cirrhosis
- Interferon Treatment
- Hepatic Resection

## Interventions

- **DRUG:** Interferon alpha-2b

## Key facts

- **NCT ID:** NCT00273247
- **Lead sponsor:** National Cancer Institute, Milan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-06
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 150 (—)
- **Last updated:** 2006-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00273247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00273247, "Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00273247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*